LOS ANGELES CAPITAL MANAGEMENT LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1177206
LOS ANGELES, CA
Position in REGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$60,945,843
-$16,633,266 QoQ
Shares Held
78,880
-21.5% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 62.43407707910751.ToString("F0")%
Shared 0.ToString("F0")%
None 37.5659229208925.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $690,323,052 across 153 Biotechnology names. REGN ranks #3 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
2,144,847 | $201,872,999 | |
| 2 | EXEL |
Exelixis, Inc.
|
3,102,634 | $133,071,972 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
78,880 | $60,945,843 | |
| 4 | RPRX |
Royalty Pharma plc
|
971,927 | $46,623,338 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
689,915 | $44,589,206 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
2,289,602 | $40,938,083 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
88,278 | $29,208,541 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
64,937 | $28,996,967 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,945,843 | 78,880 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $77,579,109 | 100,508 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $53,604,010 | 95,335 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $3,889,725 | 7,409 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,924,795 | 7,765 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $374,685 | 526 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,850,182 | 1,760 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,662,258 | 2,533 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,196,375 | 1,243 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $4,694,460 | 5,345 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $576,072 | 700 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $397,352 | 553 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $32,247,260 | 39,246 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $31,942,526 | 44,273 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $37,239,623 | 54,059 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $33,882,980 | 57,319 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $39,233,743 | 56,175 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $70,032,410 | 110,895 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $20,452,058 | 33,795 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $24,685,792 | 44,197 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $12,133,202 | 25,644 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,706,827 | 3,533 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $6,064,096 | 10,833 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $9,717,090 | 15,581 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $12,992,908 | 26,609 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||